During the past decade, Diabetes-Praxis Muenster conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Diabetes-Praxis Muenster" #1 collaborator was "Boehringer Ingelheim" with 1 trials as a collaborator, "DexCom, Inc. a Delaware corporation, USA" with 1 trials as a collaborator, "Federal Ministry of Health, Germany" with 1 trials as a collaborator, "German Center for Diabetes Research" with 1 trials as a collaborator and "Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm, Germany" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Diabetes-Praxis Muenster" are "Diabetes Mellitus, Type 2" (2 trials), "Type 2 Diabetes" (2 trials), "Diabetes" (1 trials), "Non-alcoholic Fatty Liver Disease (NAFLD)" (1 trials) and "Non-alcoholic Steatohepatitis (NASH)" (1 trials). Many other conditions were trialed in "Diabetes-Praxis Muenster" in a lesser frequency.

Most popular intervention types in "Diabetes-Praxis Muenster" are "Device" (3 trials) and "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Continuous Glucose Monitoring System" (1 trials), "Empagliflozin 10mg oral tablet / Semaglutide 1mg pen injector" (1 trials), "Empagliflozin 10mg oral tablet and placebo pen injector matching semaglutide" (1 trials), "Insulin Efsitora Alfa" (1 trials) and "Insulin Glargine (U100)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Diabetes-Praxis Muenster" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Diabetes-Praxis Muenster". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Diabetes-Praxis Muenster, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Diabetes-Praxis Muenster, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".